Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 2,325.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 3,950.00p
  • 52 Week Low: 2,266.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,828
  • Market Cap: £121.48m

Regulatory News

Holding(s) in Company 13-Aug-2025 14:19 RNS
Director Dealing 28-Apr-2025 17:13 RNS
Exercise of Options and Issue of Equity 11-Apr-2025 07:00 RNS
Interim Results 31-Mar-2025 07:00 RNS
Director Dealing 24-Dec-2024 09:14 RNS
Result of AGM 06-Dec-2024 07:00 RNS
Holding(s) in Company 04-Dec-2024 15:34 RNS
Director/PDMR Shareholding 22-Nov-2024 15:56 RNS
Notice of AGM 08-Nov-2024 07:57 RNS
Director/PDMR Shareholding 31-Oct-2024 07:00 RNS
Results for the year ended 30 June 2024 28-Oct-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 10:37 RNS
Holding(s) in Company 16-Oct-2024 13:51 RNS
Director/PDMR Shareholding 30-Apr-2024 07:00 RNS
Holding(s) in Company 12-Apr-2024 11:05 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,325.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 3,950.00p
52 Week Low 2,266.00p
Volume 1,828
Shares Issued 5.22m
Market Cap £121.48m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 24-Oct-2025

Time Volume / Share Price
14:34 1 @ 2,272.00p
14:24 212 @ 2,348.00p
14:08 8 @ 2,348.00p
14:06 1 @ 2,272.00p
13:53 1 @ 2,272.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page